Pyxis Oncology Q3 EPS $(0.85) Up From $(8.96) YoY
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.85) per share. This is a 90.51 percent increase over losses of $(8.96) per share from the same period last year.
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Pyxis Oncology Announces Preclinical Data On Anti-Siglec-15 BSI-060T Presented By Biosion At AACR Annual Meeting
Pyxis Oncology, Inc. (NASDAQ:PYXS) today announced preclinical data supporting the potential of anti-Siglec-15 BSI-060T (now PYX-106) presented by Biosion, Inc. at the 2022 American Association for Cancer Research